| CASE REPORT |
|
| Year : 2013 | Volume
: 58
| Issue : 2 | Page : 142-144 |
|
|
Multifocal fixed drug eruption with COX-2 inhibitor-celecoxib
Shikha Chugh1, Rashmi Sarkar1, Vijay K Garg1, Avninder Singh2, Chitralekha Keisham3
1 Department of Dermatology, Maulana Azad Medical College and Associated Lok Nayak Hospital, New Delhi, India
2 Department of Pathology, National Institute of Pathology, ICMR, Safdarjang, New Delhi, India
3 Department of Dermatology, Jawaharlal Institute of Medical Science, Porampat, Manipur, India
Correspondence Address:
Rashmi Sarkar
Department of Dermatology, Maulana Azad Medical College and Associated Lok Nayak Hospital, New Delhi
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0019-5154.108057
|
|
|
Cyclooxygenase-2 (COX-2) inhibitors are rapidly becoming the first choice nonsteroidal anti-inflammatory drugs (NSAIDs) for various rheumatological and other painful conditions. However, they might not be as safe or free of side effects as they are considered to be. These COX-2inhibitors may cause a variety of dermatological and systemic side effects of which we should be aware to avoid their indiscriminate use. We hereby report a case of multifocal fixed drug eruption (FDE) with celecoxib which has not yet been reported in Indian settings. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
